The Role of Serum Leptin Levels in Multiple Sclerosis Disease Activity While on Interferon Beta 1a (Rebif) Treatment

Impact of Disease Modifying Therapies (DMTs) and Associated Support Services in Relapsing Multiple Sclerosis (RMS) Patients

NCT01601119 ·Status: COMPLETED

fMRI Study of Treatment Recommendations Comparing Recently Diagnosed Multiple Sclerosis (MS) Patients to Controls

NCT00391352 ·Status: COMPLETED

Multimodal MRI in Multiple Sclerosis (MS): Reliability and Follow Up

NCT00289159 ·Status: UNKNOWN

Evaluation of Emotional Disorders During Treatment by Interferon Beta in Relapsing-remitting Multiple Sclerosis Patients

NCT01201343 ·Status: COMPLETED ·Phase: PHASE4

An Observational Study to Evaluate Quality of Life (QoL) and Influence of Cognitive Status on QoL in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS) During 2 Years Treatment With Rebif New Formulation (RNF)

NCT01110993 ·Status: COMPLETED

An Observational Study of Multiple Sclerosis (MS) Patients Starting or Restarting Baseline Treatment With Interferon Beta 1a After the Use of Escalation Treatment With Mitoxantrone

NCT01142518 ·Status: COMPLETED

Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis

NCT00110396 ·Status: COMPLETED ·Phase: PHASE3

Study of Brain Activations and Physiological Responses Using NeuroBiofeedback in Patients With Multiple Sclerosis

NCT06239090 ·Status: RECRUITING ·Phase: NA

Rebif Compliance Support Program - Assessing Needs in Multiple Sclerosis

NCT01080573 ·Status: COMPLETED

Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis

NCT00997438 ·Status: COMPLETED ·Phase: PHASE1

An Observational Study Evaluating Therapy Optimisation Using High-frequency and High-dosage Administration of Interferon-beta (Rebif®) in Multiple Sclerosis (MS) Patients

NCT01142453 ·Status: COMPLETED

A Postmarketing Surveillance (PMS) Study to Evaluate the Extent to Which Patient Compliance is Influenced by Use of a Variable Titration Regimen at the Start of Treatment of Relapsing Multiple Sclerosis (MS) With Interferon Beta 1a (Rebif®)

NCT01142492 ·Status: COMPLETED

Real-Life Outcomes of Multiple Sclerosis Treatment With Rebif

NCT02377323 ·Status: COMPLETED ·Phase: NA

Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms

NCT00919217 ·Status: TERMINATED

Use of a Smartphone Application to Predict the Prognosis in Patients With Newly Diagnosed Multiple Sclerosis.

NCT04595799 ·Status: ACTIVE_NOT_RECRUITING

Rebif New Formulation (RNF) Quality of Life (QOL) Study

NCT00472797 ·Status: COMPLETED ·Phase: PHASE3

Transition to Rebif New Formulation

NCT00619307 ·Status: COMPLETED ·Phase: PHASE3

An Observational Study Comparing Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL) and Multiple Sclerosis Quality of Life-54 Instrument (MSQOL-54) in Relapsing Multiple Sclerosis (RMS) Patients on Long-term Rebif® Therapy

NCT01141751 ·Status: COMPLETED

A Multi-center, Multi-regional Observational Study to Test the Responsiveness of the Validated MusiQoL (Multiple Sclerosis International Quality of Life Questionnaire) Instrument to EDSS Status Changes in Any Form of Multiple Sclerosis (MS) in Patients With or Without Treatment

NCT00702065 ·Status: COMPLETED

Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)

NCT00001248 ·Status: RECRUITING

A Study of Rebif® in Subjects With Relapsing Multiple Sclerosis

NCT02064816 ·Status: COMPLETED ·Phase: PHASE4

Therapy Optimization in Multiple Sclerosis (MS)

NCT00819000 ·Status: COMPLETED

The Regulatory Role of miRNA 27 Follistatin Like Protein-1 Gene in Multiple Scelerosis

NCT06290453 ·Status: NOT_YET_RECRUITING

Correlation Between Relapses in Multiple Sclerosis (MS) and Vitamin D Intake

NCT01994018 ·Status: COMPLETED

Post-Authorization Observational Study to Evaluate Cognition and Fatigue in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Treated With Rebif®

NCT01075880 ·Status: COMPLETED